FoxBio Company

FoxBio, Inc. is a joint venture of Antoxerene, Inc., a portfolio company of Ichor Therapeutics, Inc., focused on small molecule drug discovery for pathways of aging, with Juvenescence Limited. FoxBio is a developer of a small molecules techniques intended to reduce senescent cells in human bodies. The company's techniques targets the pro-survival pathways of senescent cells to remove them from the body, enabling patients to have multiple health benefits and delay the onset of age related diseases.
Technology: Geroscience
Industry: Small&Large Molecules
Headquarters: Lafayette, Louisiana, United States
Founded Date: 2018
Investors Number: 2
Total Funding: 10000000
Last Funding Date: 2018
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership